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Background: The co-activator-associated arginine methyltransferase 1 (CARM1) catalyzes the methylation of HuR.
However, the functional impact of this modification is not fully understood. Here, we investigated the influence of
HuR methylation by CARM1 upon the turnover of HuR target mRNAs encoding senescence-regulatory proteins.
Results: Changing the methylation status of HuR in HeLa cells by either silencing CARM1 or mutating the major
methylation site (R217K) greatly diminished the effect of HuR in regulating the turnover of mRNAs encoding cyclin
A, cyclin B1, c-fos, SIRT1, and p16. Although knockdown of CARM1 or HuR individually influenced the expression of
cyclin A, cyclin B1, c-fos, SIRT1, and p16, joint knockdown of both CARM1 and HuR did not show further effect.
Methylation by CARM1 enhanced the association of HuR with the 3′UTR of p16 mRNA, but not with the 3′UTR of
cyclin A, cyclin B1, c-fos, or SIRT1 mRNAs. In senescent human diploid fibroblasts (HDFs), reduced CARM1 was
accompanied by reduced HuR methylation. In addition, knockdown of CARM1 or mutation of the major
methylation site of HuR in HDF markedly impaired the ability of HuR to regulate the expression of cyclin A, cyclin
B1, c-fos, SIRT1, and p16 as well to maintain a proliferative phenotype.
Conclusion: CARM1 represses replicative senescence by methylating HuR and thereby enhancing HuR’s ability to
regulate the turnover of cyclin A, cyclin B1, c-fos, SIRT1, and p16 mRNAs.
Keywords: CARM1, HuR methylation, mRNA turnover, Replicative senescenceBackground
RNA binding protein HuR, the ubiquitously expressed
member of Hu RNA binding proteins [1], is functionally
involved in the regulation of mRNA stabilization, trans-
lation, and export [2-4]. Among the cellular events that
are influenced by HuR and its target mRNAs is the
process of replicative senescence. Several studies have
implicated HuR in regulating the turnover of cyclin A,
cyclin B1, c-fos, SIRT1, and p16 mRNAs, as well as the
nuclear export of HuR mRNA during replicative senes-
cence [4-8].
Although the molecular events controlling HuR function
are not fully understood, the cytoplasmic presence and
post-translational modification (e.g., phosphorylation and
methylation) of HuR are particularly important [2,9-11].* Correspondence: xiaoweizhang@bjmu.edu.cn; wwg@bjmu.edu.cn
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reproduction in any medium, provided the orFor example, the cell cycle checkpoint kinase Chk2 has
been shown to interact with HuR and phosphorylate HuR
at residues S88, S100, and T118; phosphrylation at S100
seems to be important for the dissociation of the HuR-
SIRT1 mRNA complex in response to oxidative stress [6].
The cyclin-dependent kinase 1 (CDK1) phosphorylates the
HuR hinge region at serine 202 and leads to enhanced HuR
association with 14-3-3, thereby retaining HuR in the nu-
cleus [11]. Additionally, studies by Doller and coworkers
identified HuR as a substrate for both PKCα and PKCδ.
The phosphorylation of HuR at S221 by both PKCα and
PKCδ is also linked to HuR shuttling as well as the
stabilization of COX-2 mRNA [12]. These findings under-
score functional links between HuR and the aforemen-
tioned signaling cascades, which regulate HuR shuttling or
its binding to target mRNAs.
Besides phosphorylation, methylation is another important
post-translational modification of HuR. The co-activator as-
sociated arginine methyltransferase 1 (CARM1) catalyses
the methylation of HuR and HuD in vitro and in vivod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Pang et al. BMC Molecular Biology 2013, 14:15 Page 2 of 11
http://www.biomedcentral.com/1471-2199/14/15[13,14]. CARM1 has been reported to methylate the his-
tones (e.g.,H3,H4) and transcriptional factors [e.g., p53,
hormone-activated nuclear receptor (NR), etc.] at arginine
residues, thereby activating gene transcription [15-18].
Methylation by CARM1 enhances the function of HuD
and HuR in stabilizing TNF-α and SIRT1 mRNAs [14,19],
respectively. The R217 present within the HuR hinge re-
gion is identified as the major methylation site by CARM1
[13]. It was proposed that the interaction of HuR nuclear
ligands SETα/β, pp32, and APRIL with the HuR hinge re-
gion regulates HuR shuttling [2]. However, thus far, the
functional impact of CARM1-mediated HuR methylation
on replicative senescence and the precise mechanism
underlying remain largely unexplored.
In this study, by using two approaches to mimic the
hypomethylation of HuR, knockdown of CARM1 and mu-
tation of HuR at the major methylation site (R217), we
have investigated the functional impact of the CARM1-
mediated HuR methylation and the mechanisms under-
lying in replicative senescence. Our results indicate that
the methylation by CARM1 is critical for HuR to regulate
the turnover of mRNAs encoding cyclin A, cyclin B1, c-fos,
SIRT1, and p16 in replicative senescence.
Results
Methylation by CARM1 enhances the effect of HuR in
regulating the turnover of cyclin A, cyclin B1, c-fos, SIRT1,
and p16 mRNAs
Because HuR has been reported to stabilize cyclin A, cyc-
lin B1, c-fos, and SIRT1 mRNAs, and destabilize p16
mRNA [5-7], we asked if CARM1-mediated HuR methyla-
tion influences the expression of these genes. To begin to
answer this question, whole-cell lysates from Hela cells si-
lenced CARM1 were subjected to immunoprecipitation
assays (IP) by using HuR antibody, whereupon the levels
of methylated and total HuR in the IP materials were de-
termined by Western blot analysis using M/DMA and
HuR antibodies, respectively. As shown in Figure 1A, the
level of methylated HuR (M- HuR) was reduced by ~80%
in cells with silenced CARM1, while total HuR levels
remained unchanged. By Western blot analysis, knock-
down of CARM1 reduced the protein levels of CARM1
(by ~90%), cyclin A (by ~70%), cyclin B1 (by ~70%), c-fos
(by ~80%), and SIRT1 (by ~70%), and increased the pro-
tein level of p16 (by ~3.4 fold) (Figure 1B). In agreement
with the results shown in Figure 1A, knockdown of
CARM1 did not alter HuR protein abundance. These re-
sults suggest that CARM1-mediated methylation may en-
hance the effect of HuR in regulating the turnover of its
target mRNAs. To confirm this point, the levels of cyclin
A, cyclin B1, c-fos, SIRT1, and p16 in HeLa cells express-
ing flag-HuR (flag-HuR, W) or flag-HuRΔ [flag-HuRΔ,
mutant (M)] were assessed by Western blotting. A mutant
HuR bearing an arginine-to-lysine mutation on residue217, identified as the major methylation site of HuR
[13] was expressed as a fusion protein (flag-HuRΔ).
After IP using anti-flag antibody (M2), the methylation
status of flag-HuR and flag-HuRΔ was assessed by
Western blotting using M/DMA antibody, as described
in Figure 1A. As shown in Figure 1C, the methylation of
flag-HuRΔ (M-flag) was reduced by ~80% relative to
that of flag-HuR (lane 1 vs. lane 2). On the other hand,
knockdown of CARM1 reduced the methylation status
of flag-HuR (by ~90%) (lane 1 vs. lane 3), but not that of
flag-HuRΔ (lane 2 vs. lane 4). We next tested the pro-
tein levels of cyclin A, cyclin B1, c-fos, SIRT1, and p16
in HeLa cells expressing flag-HuR (W) or flag-HuRΔ
(M) by Western blotting. In keeping with previous find-
ings [5-7], expression of flag-HuR (lanes 2, W) in-
creased the levels of cyclin A (by ~4.2 fold), cyclin B1
(by ~2.8 fold), c-fos (by ~4.6 fold), and SIRT1 (by ~5.1
fold), and reduced the levels of p16 (by ~90%), com-
pared to the levels of these proteins in cells transfected
with the empty vector (lanes 1, -) (Figure 1D). However,
expression of flag-HuRΔ (lanes 3, M) elicited a much
weaker effect on protein levels: cyclin A increased only
by ~1.3 fold, cyclin B1 by ~1.2 fold, c-fos by ~1.8 fold,
and SIRT1 by ~2.0 fold, while p16 levels were reduced
by ~60% (Figure 1D).
We next asked if CARM1 functions through methylat-
ing HuR. HeLa cells were transfected with HuR siRNA,
CARM1 siRNA or both siRNAs, and 48 h later, the levels
of cyclin A, cyclin B1, c-fos, SIRT1, and p16 were assessed
by Western blot analysis. As anticipated, knockdown of
HuR (lanes 2) or CARM1 (lanes 3) individually reduced
the levels of cyclin A, cyclin B1, c-fos, and SIRT1, and in-
creased the levels of p16 (Figure 1E). However, joint
knockdown of HuR and CARM1 (lanes 4) was not more
effective than individual knockdown of HuR or CARM1
(Figure 1E). In sum, by methylating HuR, CARM1 is able
to regulate the expression of cyclin A, cyclin B1, c-fos,
SIRT1, and p16.
Next, we measured the levels and half-lives of cyclin A,
cyclin B1, c-fos, SIRT1, and p16 mRNAs in cells described
in Figure 1B and 1D, as described in ‘Methods’. As shown
in Figure 2A, silencing CARM1 reduced the levels of cyclin
A (by ~83%), cyclin B1 (by ~78%), c-fos (by ~76%), and
SIRT1 (by ~69%), but induced that of p16 (by ~4.1 fold).
As anticipated, knockdown of CARM1 shortened the half-
lives of cyclin A (3.2 h vs. 2.2 h, p = 0.028), cyclin B1 (3.2 h
vs. 2.3 h, p = 0.025), c-fos (3.7 h vs. 2.8 h, p = 0.027), and
SIRT1 (3.3 h vs. 2.3 h, p = 0.026) mRNAs, and extended the
half-life of p16 mRNA (2.8 h vs. 3.7 h, p = 0.018)
(Figure 2C). As a negative control, knockdown of CARM1
did not influence the levels (Figure 2A) orhalf-lives
(Figure 2C) of β-tublin mRNA (4.9 h vs. 5.1 h, p = 0.218).
In keeping with previous findings [5-7], expression of
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p16 (fold) 1 3.3 3.2 3.4
Figure 1 Methylation by CARM1 enhances the regulating of cyclin A, cyclin B1, c-fos, SIRT1, and p16 by HuR. (A) Forty-eighth after
transfection of HeLa cells with CARM1siRNA (+) or a control siRNA (−), lysates were prepared for IP assays by using HuR antibody. The presence of
total and methylated HuR in the IP materials was determined by Western blot analysis by using M/DMA and HuR antibodies, respectively. (B) Cell
lysates described in Figure 1A were subjected to Western blot analysis to assess the protein levels of CARM1, HuR, cyclin A, cyclin B1, c-fos, SIRT1,
p16, and GAPDH. Western blotting signals were quantified by densitometry. (C) HeLa cells were transfected with a vector expressing flag-HuR or
flag-HuRΔ. Twenty fourh later, cells were further transfected with CARM1 siRNA or a control siRNA and cultured for an additional 48 h. Whole-cell
lysates were prepared and subjected to IP assays by using anti-flag antibody (M2). Western blot analysis was performed to assess the total and
methylation levels of flag-tagged HuR in the IP materials using M/MDA and flag antibodies, respectively. (D) HeLa cells were transfected with a
vector expressing flag-HuR or flag-HuRΔ. Forty eighth later, lysates were prepared to assess the protein levels of CARM1, HuR, cyclin A, cyclin B1,
c-fos, SIRT1, p16, and GAPDH by Western blot analysis, the signals of Western blotting were quantified by densitometry. (E) HeLa cells were either
transfected with HuR or CARM1 siRNA or co-transfected with both siRNAs. Forty eighth later, Western blot analysis was performed to evaluate the
levels of CARM1, HuR, cyclin A, cyclin B1, c-fos, SIRT1, p16, and GAPDH; Western blotting signals were quantified by densitometry. Data are
representatives from 3 independent experiments.
Pang et al. BMC Molecular Biology 2013, 14:15 Page 3 of 11
http://www.biomedcentral.com/1471-2199/14/15(by ~4.2 fold), cyclin B1 (by ~4.3 fold), c-fos (by ~4.6 fold),
and SIRT1 (by ~4.9 fold), but decreased that of p16
(by ~76% ) (Figure 2B). The marked changes in steady-state
levels for these mRNAs were due in part to changes in their
stabilities [cyclin A mRNA (2.7 h vs. 4.1 h, p = 0.024), cyclin
B1 mRNA (3.1 h vs. 4.4 h, p = 0.028), c-fos mRNA (3.2 h
vs. 5.8 h, p = 0.019), SIRT1 mRNA (3.0 h vs. 4.2 h, p =
0.025) mRNAs, and p16 mRNA (3.0 h vs. 2.1 h, p = 0.019)
(Figure 2D)]. In contrast, expression of flag-HuRΔ (flag-
HuRΔ) had a much weaker effect, increasing cyclin A
mRNA levels by ~1.7 fold, cyclin B1 mRNA by ~ 1.8 fold,
c-fos mRNA by ~ 1.6 fold, and SIRT1 mRNA by ~ 1.5 fold,
and reducing p16 mRNA by ~40% (Figure 2B). As above,these changes were due in part by changes in the half-
lives of these mRNAs: cyclin A mRNA (2.7 h vs. 3.1 h,
p = 0.067), cyclin B1 mRNA (3.1 h vs. 3.4 h, p = 0.076),
c-fos mRNA (3.2 h vs. 3.4 h, p = 0.062), SIRT1 mRNA
(3.0 h vs. 3.4 h, p = 0.088), and p16 mRNA (3.0 h vs.
2.8 h, p = 0.097) (Figure 2D)]. As a negative control, the
levels (Figure 2B) and half-lives (Figure 2D) of β-tublin
mRNA in cells expressing flag-HuR were compa-
rable to that observed in cells expressing flag-HuRΔ
(Figure 2B and 2D). These results suggest that methy-
lation by CARM1 enhances HuR’s ability to regulate
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Figure 2 Methylation by CARM1 influences the effect of HuR in regulating mRNA turnover. (A and B) RNA was prepared from cells
described in Figure 1A (A) and 1D (B) to assess the mRNA levels of cyclin A, cyclin B1, c-fos, SIRT1, p16, and β-tublin by real-time qPCR against
GAPDH. (C and D) Cells described in Figure 1A and 1D were exposed to actinomycin D (2 μg/ml), whereupon the cellular RNA was isolated at
times indicated. Real-time qPCR against GAPDH was performed to assess the half-lives of cyclin A, cyclin B1, c-fos, SIRT1, p16, and β-tublin mRNA,
as described in Methods. The real-time qPCR data are represented as means ± SEM from 3 independent experiments. The statistic significance
was analyzed by Student’s t test.
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with p16 3′UTR, but not cyclin A, cyclin B1, c-fos, and
SIRT1 3′UTR
Since the changes in HuR target mRNA half-lives occurred
in the cytoplasm, it is important to ask if methylation of
HuR by CARM1 influenced the levels of cytoplasmic HuR.
To this end, the cytoplasmic, nuclear, and whole-cell frac-
tions from cells described in Figure 1B and 1D were pre-
pared as described [9] and the presence of HuR in different
cellular fractions was assessed by Western blot analysis. As
shown in Figure 3A, knockdown of CARM1had no influ-
ence on the presence of HuR in the cytoplasm or the nu-
cleus. Similarly, the total (lanes 8 and 9), cytoplasmic (lanes
2 and 3), and nuclear levels (lanes 5 and 6) of flag-HuR (W)and flag-HuRΔ (M) were relatively similar (Figure 3B).
Therefore, methylation by CARM1 did not markedly alter
the subcellular distribution of HuR.
Besides its localization, the interaction of HuR with tar-
get mRNAs influences its ability to regulate mRNA turn-
over or translation. To further test the influence of
CARM1-mediated methylation on the interaction of HuR
with RNA, biotinylated fragments of cyclin A, cyclin B1,
c-fos, SIRT1, and p16 3′UTRs and cytoplasmic extracts
described in Figure 3A and 3B were used for pull-down
and RNP IP assays, as previously described [7]. As shown
in Figure 3C and 3D, knockdown of CARM1 had no influ-
ence on the association of HuR with the 3′UTRs of cyclin
A, cyclin B1, c-fos, and SIRT1 mRNAs. In addition, the
BE
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Figure 3 Influences of CARM1-mediated methylation on the subcellular distribution and RNA-binding affinity of HuR. (A and B)
Western blot analysis was performed to assess the presence of endogenous HuR (A) as well as flag-tagged HuR (flag-HuR and flag-HuRΔ) (B) in
whole-cell (Total, 10 μg), cytoplasmic (Cyto., 40 μg), and nuclear fractions (Nuc., 5 μg) prepared from cells described in Figure 1A and 1D.
Assessment of the levels of cytoplasmic-specific tubulin and nuclear-specific HDAC1 served to verify the quality and equal loading of the
cytoplasmic and nuclear preparations, respectively. (C) Cytoplasmic extracts (100 μg) described in Figure 3A were subjected to RNA pull-down
assays using biotinylated 3′UTR fragments of cyclin A, cyclin B1, c-fos, SIRT1, and p16 to detect bound endogenous HuR by Western blotting. A
10-μg aliquot of whole-cell lysates (Lys.), binding of HuR and GAPDH to the beads (Neg.), and binding of GAPDH to the cyclin A, cyclin B1, c-fos,
SIRT1, and p16 3′UTR were also tested. (D) Cytoplasmic extracts (100 μg) described in Figure 3A were subjected to RNP IP assays using anti- HuR
antibody. The presence of cyclin A, cyclin B1, c-fos, SIRT1, and p16 mRNAs in the IP materials were assessed by real-time qPCR. (E, F) Cytoplasmic
extracts (100 μg) described in Figure 3B were either subjected to RNA pull-down assays (E) or RNP IP assays (F) to assess the association of flag-
HuR and flag-HuRΔ with the mRNAs of cyclin A, cyclin B1, c-fos, SIRT1, and p16, as described in Figure 3C and 3D. (G, H) Cytoplasmic extracts
described in Figure 3A and 3B were either used for RNA pull-down assays (G) or used for RNP IP assays (H) to assess the association of AUF1
with p16 mRNA, as described in Figure 3C and 3D.
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http://www.biomedcentral.com/1471-2199/14/15association of flag-HuR (W) and flag-HuRΔ (M) with the
3′UTR of cyclin A, cyclin B1, c-fos, and SIRT1 was
comparable (Figure 3E and 3F). However, changing HuR
methylation either by silencing CARM1 (Figure 3C and
3D) or by mutating the HuR methylation site (Figure 3E
and 3F) markedly lowered the association of HuR with
p16 3′UTR. In a previous study, HuR and AUF1 werefound to bind with the p16 3′UTR and destabilize p16
mRNA cooperatively [7]. To address whether methylation
of HuR by CARM1 influences the association of AUF1
with p16 3′UTR, the lysates described in Figure 3C and
3E were used for pull-down and RNP IP assays. As shown
in Figure 3G and 3H (left), in cells with silenced CARM1,
the association of AUF1 with p16 3′UTR was markedly
CARM1
GAPDH





HuR (fold)      1        0.1
CARM1 (fold)      1        0.1
M-HuR (fold)    1          0.1





Y     S       Y      S      Y      S     Y      S
Y      S      Y      S      Y     S
Input SIRT1  p16
Input cyclin A cyclin B1 c-fosC
D
Figure 4 CARM1 and methylated HuR reduce replicative
senescence. (A) Western blot analysis of CARM1, HuR, and GAPDH
protein levels in early-passage (Young, ~27 pdl, Y) and late-passage
(Senescent, ~60 pdl, S) 2BS cells. (B) HuR was immunoprecipitated
from the whole cell lysates (100 μg) described in Figure 3A,
whereupon the total or methylated HuR was assessed by Western
blot analysis using HuR or M/DMA antibodies, respectively. Western
blotting signals were quantified by densitometry. Data are
representative from 3 independent experiments. (C) Cytoplasmic
extracts prepared from cells described in Figure 4A were subjected
to RNA pull-down assays using biotinylated 3′UTR fragments of
cyclin A, cyclin B1, c-fos, SIRT1, and p16 to detect bound HuR by
Western blotting. A 10-μg aliquot of whole-cell lysates (Input) and
binding of GAPDH to the cyclin A, cyclin B1, c-fos, SIRT1, and p16 3′
UTR were also tested. (D) Cytoplasmic extracts described in
Figure 4C were subjected to RNP IP assays using anti-flag antibody,
the presence of cyclin A, cyclin B1, c-fos, SIRT1, and p16 mRNAs in
the IP materials were assessed by real-time qPCR.
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association of AUF1 with the p16 3′UTR was substantially
weaker than that observed from cells expressing flag-HuR
(W) (Figure 3G and 3H, right). These results suggest that
methylation by CARM1 enhances the association of HuR
with the p16 3′UTR, and in turn, enhances the association
of AUF1 with the p16 3′UTR.
CARM1- HuR regulatory process impacts on replicative
senescence
HuR regulates replicative senescence at least in part by sta-
bilizing cyclin A, cyclin B1, c-fos, and SIRT1 mRNAs as well
as destabilizing p16 mRNA [5-7]. To address whether the
methylation of HuR by CARM1 impacts upon replicative
senescence, we first examined the levels of CARM1
and the methylation status of HuR in early-passage
[Young, ~27 population doublings (pdl)] and late-
passage [Senescent, ~60 (pdl)] human diploid fib-
roblasts (2BS) by Western blotting. As shown in
Figure 4A, the levels of CARM1 in senescent 2BS cells
(S) were markedly reduced relative to the levels in
young 2BS cells (Y). As a positive control, HuR protein
levels in the senescent cells were also potently reduced,
in keeping with previous findings [4]. To evaluate the
methylation status of HuR in senescent cells, HuR was
immunoprecipitated from lysates prepared from cells
described in Figure 4A. The IP materials then were
subjected to Western blot analysis using the M/DMA
antibody. As anticipated, the levels of both methylated
HuR (M- HuR) and total- HuR ( HuR) were markedly
reduced in senescent cells (Figure 4B). In addition, re-
duction of HuR and CARM1 protein levels as well as
the HuR methylation levels was accompanied with the
decrease of the association of HuR with cyclin A, cyc-
lin B1, c-fos, SIRT1, and p16 mRNAs in senescent cells
(Figure 4C and 4D).
Next, we evaluated the functional impact of the methyla-
tion of HuR by CARM1 in replicative senescence. 2BS cells
were transfected with a vector expressing CARM1 shRNA
or control shRNA and selected by G418 for 3 weeks. As in-
dicated in Figure 5A, knockdown of CARM1 led to a
reduction in the levels of cyclin A (by ~80%), cyclin B1
(by ~80%), c-fos (by ~60%), and SIRT1 (by ~70%), and to
an induction in p16 levels (by ~3.9 fold) (Figure 5A).
Knockdown of CARM1 decreased S and G2 compartments
(Figure 5B) and increased the number of SA-β-gal positive
cells (21% vs. 35%, p = 0.034) (Figure 5C). In accordance
with previous findings [5-7], 2BS cells stably transfected
with a vector expressing flag-HuR (W) increased the pro-
tein levels of cyclin A (by ~3.8 fold), cyclin B1 (by ~3.6
fold), c-fos (by ~4.4 fold), and SIRT1 (by ~3.6 fold), and
decreased the levels of p16 (by ~90%) (Figure 6A), thereby
increasing the S and G2 compartments (Figure 6B), and
decreasing the number of SA-β-gal positive cells (67% vs.23%, p = 0.003) (Figure 6C). In contrast, expressing flag-
HuRΔ (M) was less effective than expressing flag-HuR (W)
in inducing the levels of cyclin A (by ~1.6 fold), cyclin B1
(by ~1.5 fold), c-fos (by ~2.0 fold), and SIRT1 (by ~1.7
fold), and reducing p16 protein level (by ~60%) (Figure 6A).
Accordingly, expressing flag-HuRΔ was less effective than
expressing flag-HuR in increasing the S and G2 compart-
ments (Figure 6B), as well as in decreasing the number of
SA-β-gal positive cells (67% vs. 53%, p = 0.050) (Figure 6C).
These findings suggest that the CARM1- HuR regulatory
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CARM1 (fold)     1         0.2    
cyclin A (fold)     1         0.2     
cyclin B1 (fold)     1         0.2     
c-fos (fold)     1         0.4    
SIRT1 (fold)     1        0.3    
p16 (fold)     1        3.9    
Figure 5 Knockdown of CARM1 reduces the levels of HuR target mRNAs and accelerates cell senescence. (A) Human diploid fibroblasts
(2BS) were stably transfected with a vector expressing CARM1 shRNA or control shRNA. The levels of CARM1, cyclin A, cyclin B1, c-fos, SIRT1, p16,
and GAPDH were assessed by Western blotting and the signals quantified by densitometry. (B, C) Cells described in Figure 5A were subjected to
FACS analysis (B) and SA-β-gal staining (C) to assess the cell cycle distribution and senescent status. The SA-β-gal staining was represented as
means ± SDs from three independent experiments. The statistic significance was analyzed by Student’s t test.
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The present study provides novel insight into the regulation
of HuR function in replicative senescence. By modulating
the HuR methylation status, we gained evidence to support
the view that methylation by CARM1 critically affects
HuR’s ability to regulate the levels of cyclin A, cyclin B1, c-fos, SIRT1, and p16 as well as the process of cell senescence
(Figures 1, 2, 4, 5, and 6).
Reduced HuR levels and cytoplasmic concentration have
been linked to the lower expression of cyclin A, cyclin B1,
c-fos, and SIRT1 and the increased expression of p16 in
replicative senescence [5-7]. Thus, signaling events that
Figure 6 Mutation of the methylation site attenuates the effect of HuR in regulating mRNA turnover and cell senescence. (A) Human
diploid fibroblasts were stably transfected with a vector expressing flag-HuR (W) or flag-HuRΔ (M), or an empty vector (−). Western blot analysis
was performed to assess the protein levels of HuR, cyclin A, cyclin B1, c-fos, SIRT1, p16, and GAPDH, and quantified by densitometry. (B,C) Cells
described in Figure 6A were subjected to FACS analysis (B) and SA-β-gal staining (C) to analyze the cell cycle distribution and cell senescent
status, as described in Figure 5B and 5C. Values of the SA-β-gal staining represent means ± SDs of the results from three independent
experiments. Statistical significance was analyzed by Student’s t test.
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cytoplasm may also involve in the process of cell aging [4].
Although the mechanism controlling HuR shuttling has
not been fully elucidated, the hinge region of HuR is of
great importance for its nuclear localization [2]. Because
the Arg217 localizes at the hinge region, we hypothesized
that the methylation of HuR by CARM1 may elevate the
expression of HuR targets by increasing the cytoplasmic
presence of HuR. However, lowering HuR methylation by
either silencing CARM1 or mutating the major methylation
site had no effect on the shuttling of HuR (Figure 3A, B).
It is also possible that methylation of HuR affects its RNA-
binding affinity because methylation may affect the inter-
action of HuR with the hinge-binding proteins, which could
in turn modulate RNA binding [13]. Indeed, ithas beenreported that methylation by CARM1 could enhance the
association of HuR with SIRT1 3′UTR during the differen-
tiation of human embryonic stem cells (hESC) [19]. Here,
loss of HuR methylation either by silencing CARM1 or by
mutating the major methylation site did not influence
the association of HuR with the 3′UTRs of SIRT1, cyc-
lin A, cyclin B1 or c-fos. However, methylation of HuR by
CARM1 enhanced the association of HuR to p16 3′UTR
(Figure 3C-H). Therefore, whether methylation by CARM1
influences the binding affinity of HuR may not only depend
on the methylation status of HuR and the mRNAs targeting
by HuR, but also on the type and physiologic state of the
cell in which the HuR-mRNA interaction occurs.
In addition to HuR and HuD, methylation of poly(A)-
binding protein 1, CA150, the SAP49, SmB, and the U1
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cated in the process of mRNA stabilization as well as the 5′
splice site selection of the pre-mRNA splicing [20-22].
Methylation of hnRNP A2, the nuclear poly (A)-binding
protein PABPN1, and the poly (U)-binding proteins Sam68
and SLM by PRMT1 influences their function and proper
localization [23-25]. Because both the expression and
methylation status of HuR significantly decline with replica-
tive senescence (Figure 4), it is challenging to evaluate the
contribution of CARM1-mediated methylation to the re-
duction of HuR methylation in senescent cells. However,
the evidence presented here (Figures 5 and 6) suggests that
the CARM1- HuR regulatory process do contribute to the
regulation of genes associated with replicative senescence.
Although the links between human aging and replicative
senescence are not fully understood, senescent cells accu-
mulate with advancing age and actively contribute to
physiologic and pathologic changes of aging. Our finding
that CARM1 contributes to the alterations of cyclin A, cyc-
lin B1, c-fos, SIRT1, and p16 in replicative senescence war-
rants a careful look at CARM1 in other models of aging. In
light of the fact that HuR is also an important regulator of
cell death [26,27], cell differentiation [19,28,29], and human
cancer [10,30-32], we postulate that CARM1-HuR regula-
tory process may impact upon these processes as well.
Conclusions
CARM1-mediated protein methylation enhances the
function of HuR upon the turnover of mRNAs encoding
cyclin A, cyclin B1, c-fos, SIRT1, and p16. Methylation
by CARM1 did not influence HuR subcellular distribu-
tion or association with the 3′UTRs of cyclin A, cyclin
B1, c-fos, and SIRT1 mRNAs, but it enhanced the asso-
ciation of HuR with the p16 3′UTR. By methylating
HuR, CARM1 critically regulates replicative senescence.
Methods
Cell culture, fluorescence-activated cell sorting (FACS)
analysis, and senescence-associated β-galactosidase
(SA-β-gal) activity
Early-passage (Young, ~25-27 population doublings[pdl]),
late-passage (Senescent, ~60 pdl) human diploid 2BS fibro-
blasts (National Institute of Biological Products, Beijing,
China), and HeLa cells were cultured in Dulbecco’s modi-
fied Eagle’s medium (Invitrogen) supplemented with 10%
fetal bovine serum, 100 units/ml penicillin, and 100 μg/ml
streptomycin, at 37 C in 5% CO2. Fluorescence-activated
cell sorting (FACS) analysis, and senescence-associated β-
galactosidase (SA-β-gal) activity were performed as de-
scribed previously [5].
Constructs and transfection
For the construction of vectors expressing flag-HuR,
full-length coding region of HuR was amplified by PCRusing flag-tagged primer GGAATTCATGGACTACAA
GGACGACGATGACAAGTCTAATGGTTATGAA and
primer GCTCTAGATTATTTGTGGGACTTGTTGG and
inserted between EcoRI sites of pcDNA 3.1 vector
(Clontech). The flag-HuR bearing an arginine-to-lysine mu-
tation on residue 217 were generated using QuikChange® II
Site-Directed Mutagenesis Kit (Stratagene) and inserted be-
tween EcoR and Xbal sites of pcDNA 3.1 (Clontech). For
construction of vectors expressing CARM1 or control
shRNAs, oligonucleotides corresponding to siRNA targeting
CARM1 (CAGCTCT ACATGGAGCAGT), HuR
(AAGAG GCAAUUACCAGUUUCA), or a control
shRNA (AAGTGTAGTAGATC ACCAGGC) were
inserted between the hind III and BgIIIsites in pSuper.
retro (Oligoengine) vector following the manufac-
turer’s instructions.
All plasmid or siRNA transfection in HeLa cells were
performed using lipofectamine 2000 (for plasmids) or
oligofectamine (for siRNAs) (Invitrogen) following the
manufacturer’s instructions. Cells were collected 48 h
after transfection for further analysis. To establish lines
stably expressing flag-HuR, flag-HuRΔ, or CARM1
shRNA, early-passage (~25 pdl) 2BS cells were trans-
fected with a vector expressing flag-HuR, flag-HuRΔ,
CARM1 shRNA, or with the respective control vectors
by lipofectamine 2000 (Invitrogen) following the manu-
facturer’s instructions, selected by G418 (300 μg/ml,
Invitrogen) for 3–4 weeks, and maintained in medium
supplemented with 50 μg/ml G418.
Preparation of cell fractions, immunoprecipitation (IP)
assays, and Western blot analysis
Whole-cell lysates as well as cytoplamic and nuclear ex-
tracts were prepared as described previously [9]. IP as-
says were performed using 50 μg of whole-cell lysates
and 1 μg of HuR or flag antibody (M2). For Western
blot analysis, lysates were size fractionated by SDS-
PAGE and transferred onto poly-vinylidene difluoride
(PVDF) membranes. Monoclonal antibodies recognizing
HuR, HDAC1, p16, c-fos, SIRT1, β-tubulin, and GAPDH
were from Santa Cruz Biotechnologies (Santa Cruz, Calif.).
Mouse monoclonal flag antibody (M2) was from Sigma.
Mouse monoclonal mono/dimethyl arginine antibody
(M/DMA) was from Abcam. After secondary antibody
incubation, signals were detected by Super Signal West
Pico Chemiluminescent Substrate (Pierce) following the
manufacturer’s instruction.
RNA-protein interaction assays and UV crosslink RNP IP
assays
cDNA was used as a template for PCR amplification to
generate the 3′UTR of different HuR target transcripts.
All 5′ primers contained the T7 promoter sequence
CCAAGCTTCTAATACGACTCACTATAGGGAGA-.
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B1, c-fos, SIRT1, and p16 mRNAs, primers (T7) CCAG
AGACATAAATCTGTAAC and GGTAACAAATTTC
TGGTTTATTTC for cyclin A 3′UTR, primers (T7)
CTTGTAAACTTGAGTTGGAGT and TTTTTTTTT
TTTGTATTTGAG for cyclin B1 3′UTR, primers (T7)
GCAATGAGC CTTCCTCTGAC and CATTCAACT
TAAATGCTTTTATTG for c-fos 3′UTR, primers (T7)
AACTATCCATCAAACAAA and TATCCAGTCATTA
AACAGT for SIRT1 3′UTR, and primers TTGGTCC
CTCTTGATTAT and GTGATGTCTGGCTGTTTC for
p16 3′UTR were used, respectively. For biotin pull-down
assays, PCR-amplified DNA was used as template to tran-
scribe biotinylated RNA by using T7 RNA polymerase in
the presence of biotin-UTP, as described [9]. One micro-
gram of purified biotinylated transcripts were incubated
with 100 μg of cytoplasmic extracts for 30 min at room
temperature. Complexes were isolated with paramagnetic
streptavidin-conjugated Dynabeads (Dynal, Oslo), and the
pull-down material was analyzed by Western blotting.
For cross-linking of RNP IP complexes, cells were
exposed to UVC (400 mJ/cm2) and whole-cell lysates
prepared for immunoprecipitation using monoclonal
anti-HuR and polyclonal anti-AUF1 antibodies, as des-
cribed [7]. The transcripts present in the RNP complexes
were analyzed by real-time qPCR.RNA isolation, real-time qPCR, and mRNA half-life
measurement
Total cellular RNA was prepared using RNeasy Mini
Kit (Qiagen) following the manufacturer’s protocol. For
real-time qPCR against GAPDH analysis to detect cyclin A,
cyclin B1, c-fos, SIRT1, p16, and β-actin transcripts, primers
TTGGTCCCTCTTGATTAT and GTGATGTCTGGCTGT
TTC for cyclin A, primers GCACTTTCCTCCTTCTCA
and CGATGTGGCATACTTGTT for cyclin B1, primers
CGAAGGGAAAGGAATAAGATG and TGAGCTGCCA
GGATGAACT for c-fos, primers TAGGCGGCTTGATG
GTAATC and TCATCCTCCATGGGTTCTTC for SIRT1,
primers GAAGGTCCCTCAGACATCCCC and CCCTGT
AGGACCTTCGGTGAC for p16, and primers GTGGACA
TCCGCAAAGAC and AAAGGGTGTAACGCAACTAA
for β-actin were used, respectively.
To measure the half-life of endogenous mRNAs, the
expression of mRNA was shut off by adding actinomycin
D (2 μg/ml) into the cell culture medium, whole cellular
RNA was prepared at times indicated and subjected to
real-time qPCR. Data were plotted as the mean ± SD
from 3 independent experiments and the half-lives were
calculated as previously described [7].Competing interests
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